BioNTech (BNTX) revenue

Revenue · fiscal 2025
€2.87B

BioNTech (BNTX) reported revenue of €2.87B in fiscal 2025 (the year ended December 31, 2025). That is 4.3% higher than the €2.75B of fiscal 2024. Figures as of 18 Nov 2026, 11:35 UTC, from Yahoo Finance.

Key facts

Revenue, fiscal 2025
€2.87B
Change on fiscal 2024
+4.3%
Highest on record
€17.31Bfiscal 2022
Lowest on record
€2.75Bfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

BioNTech revenue, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €17.31B in fiscal 2022 and the lowest €2.75B in fiscal 2024.

History · 4 fiscal years

Revenue by fiscal year

BioNTech revenue, year by year

BioNTech (BNTX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025€2.87B 4.3% up
2024€2.75B 28.0% down
2023€3.82B 77.9% down
2022€17.31B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of BioNTech and comparable companies
CompanyRevenueFiscal year
Viatris VTRS$14.30B2025
Tenet Healthcare THC$21.31B2025
BioNTech BNTX€2.87B2025
Guardant Health GH$982.02M2025
Alnylam Pharmaceuticals ALNY$3.71B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BNTX

BioNTech, figure by figure

BioNTech (BNTX) overview: price, valuation and scorecardAll health care companies by market value

BioNTech revenue: questions and answers

What is BioNTech's revenue?

BioNTech (BNTX) reported revenue of €2.87B in fiscal 2025 (the year ended December 31, 2025). That is 4.3% higher than the €2.75B of fiscal 2024.

What are the highest and lowest revenue figures on record for BioNTech?

Across the 4 fiscal years on record (2022–2025), the highest was €17.31B in fiscal 2022 and the lowest €2.75B in fiscal 2024.

How is BioNTech's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For BioNTech it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BioNTech (BNTX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/BNTX/revenue

Underlying data: Yahoo Finance.